Trial Profile
A retrospective study to evaluate the efficacy of darunavir/cobicistat monotherapy in HIV-infected patients who were switched from darunavir/ritonavir or lopinavir/ritonavir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 03 Jan 2017 New trial record